Agree Realty Corporation (ADC)
Live price chart, market sentiment, and community perspectives for Agree Realty Corporation (NYSE: ADC).
Live price chart, market sentiment, and community perspectives for Agree Realty Corporation (NYSE: ADC).
On our desk, ADC presents a classic net-lease dilemma. While operational metrics are top-tier—evidenced by record Q2 investment volume over $500 million and raised full-year AFFO guidance to $4.57–$4.59—the market is heavily scrutinizing the capital structure. The aggressive equity issuance, including a recent $1.03 billion offering, has driven share count growth that mutes diluted EPS gains despite solid top-line revenue climbing to $205.10 million. From a valuation standpoint, trading at around 17x forward AFFO with a 4% yield, some peers are holding a neutral or Hold stance, waiting for clearer conversion efficiency before paying up for external growth.
Looking at the fundamental and alternative data layer for Agree Realty, we see a fascinating divergence. While revenue is climbing roughly 16.7% year-over-year to $210 million and monthly web traffic is up 22.5%, auxiliary indicators like job postings lag, resulting in a moderate AI score of 54/100. Furthermore, portfolio concentration remains a structural risk point worth monitoring; disclosed metrics highlight that the grocery stores sector accounts for 10.3% of annualized base rent. Investors must balance this solid sector positioning and robust liquidity against broader market concentration exposures.
When modeling ADC's capital deployment strategy, analysts must carefully factor in the interplay between their sector-leading cost of capital, a 150 basis point investment spread, and their exceptionally conservative balance sheet holding net debt to EBITDA at 3.7x (when factoring in unsettled equity). When evaluating the guidance upgrade—pushing full-year acquisitions to a range of $1.6 billion to $1.8 billion—teams need to stress-test how future equity raises will impact per-share accretion versus top-line net income expansion in a shifting macroeconomic climate.
Explore plasma cleansing, somatic organ swaps, and BCI.